• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病脑中 1-乙酰基-6,7-二羟基-1,2,3,4-四氢异喹啉(ADTIQ)类似物的出现和分布。

Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains.

机构信息

School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.

出版信息

J Neural Transm (Vienna). 2012 Apr;119(4):435-41. doi: 10.1007/s00702-011-0724-4. Epub 2011 Nov 8.

DOI:10.1007/s00702-011-0724-4
PMID:22065205
Abstract

Parkinson's disease (PD) arises from the loss of dopaminergic neurons in the substantia nigra. 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) is well known to cause Parkinsonism in humans with neurotoxicity specific for dopaminergic neurons. The experience with MPTP supports the hypothesis that endogenous or xenobiotic neurotoxins are involved in the pathogenesis of PD in humans. In our study, 1-acetyl-6, 7-dihydroxy-1, 2, 3, 4-tetrahydro-isoquinoline (ADTIQ), a novel compound, was found in frozen human brain tissues. The formation of ADTIQ was demonstrated using dopamine and methylglyoxal under physiological conditions. Methylglyoxal is a by-product of glycolysis. ADTIQ and its precursors, dopamine and methylglyoxal, were detected in different regions of frozen human brains such as the substantia nigra, caudate nucleus, putamen, frontal cortex, and the cerebellum. A significant difference in ADTIQ levels between control and Parkinson's patients was found; for instance, the ADTIQ level in putamen of PD patients was 0.76 ± 0.27 nmol/g compared to 0.10 ± 0.01 nmol/g in control. Our results might indicate that ADTIQ is possibly related to Parkinson's disease.

摘要

帕金森病(PD)源于黑质中多巴胺能神经元的丧失。1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)众所周知可引起人类帕金森病,对多巴胺能神经元具有神经毒性。MPTP 的经验支持这样一种假设,即内源性或外源性神经毒素参与了人类 PD 的发病机制。在我们的研究中,在冷冻的人脑组织中发现了 1-乙酰基-6,7-二羟基-1,2,3,4-四氢异喹啉(ADTIQ),这是一种新型化合物。在生理条件下使用多巴胺和甲基乙二醛证明了 ADTIQ 的形成。ADTIQ 及其前体多巴胺和甲基乙二醛存在于不同的冷冻人脑区域,如黑质、尾状核、壳核、额叶皮质和小脑。在帕金森病患者和对照组之间发现了 ADTIQ 水平的显著差异;例如,PD 患者壳核中的 ADTIQ 水平为 0.76±0.27 nmol/g,而对照组为 0.10±0.01 nmol/g。我们的结果可能表明 ADTIQ 可能与帕金森病有关。

相似文献

1
Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains.帕金森病脑中 1-乙酰基-6,7-二羟基-1,2,3,4-四氢异喹啉(ADTIQ)类似物的出现和分布。
J Neural Transm (Vienna). 2012 Apr;119(4):435-41. doi: 10.1007/s00702-011-0724-4. Epub 2011 Nov 8.
2
A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.一种新发现的与高血糖和帕金森病相关的神经毒素ADTIQ。
Biochem Biophys Res Commun. 2015 Apr 10;459(3):361-6. doi: 10.1016/j.bbrc.2015.02.069. Epub 2015 Mar 3.
3
Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes.在高血糖细胞模型和糖尿病大鼠模型中形成一种类似萨索林醇的化合物,神经毒素 1-乙酰基-6,7-二羟基-1,2,3,4-四氢异喹啉。
Int J Mol Med. 2014 Mar;33(3):736-42. doi: 10.3892/ijmm.2013.1604. Epub 2013 Dec 24.
4
N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.大鼠脑中多巴胺衍生的6,7-二羟基-1,2,3,4-四氢异喹啉((R)-萨索林醇)的N-甲基化:体内微透析研究
J Neurochem. 1992 Aug;59(2):395-400. doi: 10.1111/j.1471-4159.1992.tb09384.x.
5
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.帕金森病中内源性类吗啡化合物免疫反应性增加。
Brain. 2011 Aug;134(Pt 8):2321-38. doi: 10.1093/brain/awr166. Epub 2011 Jul 8.
6
A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.一种多巴胺能神经毒素,1(R),2(N)-二甲基-6,7-二羟基-1,2,3,4-四氢异喹啉、N-甲基(R)萨索林醇及其氧化产物1,2(N)-二甲基-6,7-二羟基异喹啉鎓离子,在人脑黑质纹状体系统中蓄积。
Neurosci Lett. 1997 Feb 14;223(1):61-4. doi: 10.1016/s0304-3940(97)13389-4.
7
Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.急性和慢性给予1,2,3,4-四氢异喹啉和salsolinol对大鼠脑多巴胺能结构诱导的神经化学变化。
Neuroscience. 2000;96(1):59-64. doi: 10.1016/s0306-4522(99)00533-3.
8
Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain.啮齿动物、人类及帕金森病大脑中四氢异喹啉衍生物的区域分布。
J Neurochem. 2008 Dec;107(5):1398-413. doi: 10.1111/j.1471-4159.2008.05709.x.
9
N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.N-甲基-(R)-salsolinol作为一种多巴胺能神经毒素:从动物模型到帕金森病的早期标志物。
J Neural Transm Suppl. 1997;50:89-105. doi: 10.1007/978-3-7091-6842-4_10.
10
Parkinsonism-preventing activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives in C57BL mouse in vivo.1-甲基-1,2,3,4-四氢异喹啉衍生物在C57BL小鼠体内的抗帕金森病活性
Biol Pharm Bull. 2006 Jul;29(7):1401-3. doi: 10.1248/bpb.29.1401.

引用本文的文献

1
Hyperglycemia Aggravates 6-Hydroxydopamine-Induced Neuronal Ferroptosis via SLC7A11-Dependent Pathway in Diabetic PD Rat Model.高血糖通过糖尿病性帕金森病大鼠模型中依赖溶质载体家族7成员11(SLC7A11)的途径加重6-羟基多巴胺诱导的神经元铁死亡
CNS Neurosci Ther. 2025 Jul;31(7):e70487. doi: 10.1111/cns.70487.
2
Impact of diabetes mellitus type two on incidence and progression of Parkinson's disease: a systematic review of longitudinal patient cohorts.2型糖尿病对帕金森病发病率和进展的影响:纵向患者队列的系统评价
J Neural Transm (Vienna). 2025 May;132(5):627-635. doi: 10.1007/s00702-025-02882-7. Epub 2025 Jan 23.
3
Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.

本文引用的文献

1
Assessment of salsolinol N-methyltransferase activity in rat peripheral lymphocytes by liquid chromatography-electrospray time-of-flight mass spectrometry.采用液相色谱-电喷雾飞行时间质谱法评估大鼠外周血淋巴细胞中 salsolinol N-甲基转移酶的活性。
Anal Bioanal Chem. 2011 Apr;399(10):3541-5. doi: 10.1007/s00216-011-4683-2. Epub 2011 Feb 16.
2
Methylglyoxal, diabetes mellitus and diabetic complications.甲基乙二醛、糖尿病及糖尿病并发症
Drug Metabol Drug Interact. 2008;23(1-2):93-124. doi: 10.1515/dmdi.2008.23.1-2.93.
3
Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.
揭示关联:2型糖尿病与帕金森病——一种基于纳米的靶向药物递送方法
Curr Diabetes Rev. 2025;21(6):32-58. doi: 10.2174/0115733998291968240429111357.
4
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.胰高血糖素样肽1在阿尔茨海默病和帕金森病中的神经保护作用:深入综述
Front Neurosci. 2022 Sep 1;16:970925. doi: 10.3389/fnins.2022.970925. eCollection 2022.
5
Autophagy and Glycative Stress: A Bittersweet Relationship in Neurodegeneration.自噬与糖基化应激:神经退行性变中的复杂关系
Front Cell Dev Biol. 2021 Dec 23;9:790479. doi: 10.3389/fcell.2021.790479. eCollection 2021.
6
Neurotoxicity and Underlying Mechanisms of Endogenous Neurotoxins.内源性神经毒素的神经毒性及潜在作用机制。
Int J Mol Sci. 2021 Nov 26;22(23):12805. doi: 10.3390/ijms222312805.
7
Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction.糖尿病与认知障碍:糖毒性与多巴胺能功能障碍的作用。
Int J Mol Sci. 2021 Nov 16;22(22):12366. doi: 10.3390/ijms222212366.
8
The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease.涉及线粒体功能障碍的表观遗传机制:帕金森病的影响。
Brain Pathol. 2022 May;32(3):e13012. doi: 10.1111/bpa.13012. Epub 2021 Aug 20.
9
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.2型糖尿病与帕金森病关系的分析:一项系统综述
Parkinsons Dis. 2019 Nov 23;2019:4951379. doi: 10.1155/2019/4951379. eCollection 2019.
10
Repeated Methylglyoxal Treatment Depletes Dopamine in the Prefrontal Cortex, and Causes Memory Impairment and Depressive-Like Behavior in Mice.重复的甲基乙二醛处理会耗尽前额叶皮层中的多巴胺,并导致小鼠的记忆损伤和类似抑郁的行为。
Neurochem Res. 2020 Feb;45(2):354-370. doi: 10.1007/s11064-019-02921-2. Epub 2019 Nov 30.
在散发性阿尔茨海默病中检测到β-分泌酶表达升高和酶活性增强。
Nat Med. 2003 Jan;9(1):3-4. doi: 10.1038/nm0103-3.
4
Environmental toxins accelerate Parkinson's disease onset.环境毒素会加速帕金森病的发病。
Neurology. 2001 Jan 9;56(1):4-5. doi: 10.1212/wnl.56.1.4.
5
Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.急性和慢性给予1,2,3,4-四氢异喹啉和salsolinol对大鼠脑多巴胺能结构诱导的神经化学变化。
Neuroscience. 2000;96(1):59-64. doi: 10.1016/s0306-4522(99)00533-3.
6
N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.N-甲基(R)-salsolinol,一种多巴胺神经毒素,与帕金森病的关系
Adv Neurol. 1999;80:259-64.
7
Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase.氨基丙酮脱氨作用的评估,氨基丙酮是氨基脲敏感胺氧化酶的内源性底物。
Anal Biochem. 1999 May 15;270(1):97-102. doi: 10.1006/abio.1999.4058.
8
Generation of reactive oxygen species accounts for cytotoxicity of an endogenous dopaminergic neurotoxin, (R)-N-methylsalsolinol, to differentiated dopaminergic SH-SY5Y cells.活性氧的产生是内源性多巴胺能神经毒素(R)-N-甲基去甲猪毛菜碱对分化的多巴胺能SH-SY5Y细胞产生细胞毒性的原因。
J Neural Transm (Vienna). 1998;105(4-5):397-405. doi: 10.1007/s007020050065.
9
Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.N-甲基(R)-salsolinol的氧化:内源性儿茶酚异喹啉在神经毒性和神经保护中的作用
J Neural Transm Suppl. 1998;52:125-38. doi: 10.1007/978-3-7091-6499-0_14.
10
N-methyl-(R)-salsolinol and its relevance to Parkinson's disease.N-甲基-(R)-萨索林醇及其与帕金森病的关联。
Lancet. 1998 Mar 21;351(9106):850-1. doi: 10.1016/S0140-6736(05)70284-1.